The results of a study published in the American Journal of Epidemiology suggest there is a significant association between rotating-shift work and prostate cancer.

“Shift workers are known to be…

Mayo Clinic researchers have found that taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen may prevent or delay benign prostatic hyperplasia, an enlarged prostate which can…

A test used to detect prostate cancer can also help doctors know when treatment is working. A man’s prostate specific antigen, or PSA, level after seven months of hormone…

Traditionally, medical castration therapy following radiotherapy can significantly improve survival for men with locally advanced prostate cancer, compared to radiotherapy alone.

For those unwilling to…

Variables that impact management of failed primary therapy for prostate cancer (CaP) are not well defined.

In the epub version of Cancer, Dr. Krupski…

A team of U.S. scientists has developed an experimental drug treatment that kills prostate cancer cells in mice while sparing normal cells.

The approach is based on delivering small interfering…

Men with prostate cancer and their spouses/significant others are being sought for a joint study being conducted by two Los Angeles-area medical centers as part of…

Dutasteride (also known as Avodart or Duprost) appears to have a variety of beneficial effects in treating benign prostatic hyperplasia (BPH), French researchers report.

BPH, an enlargement of the prostate gland, is…

Extracts from a mushroom used for centuries in Eastern Asian medicine may be able to boost the power of a leading chemotherapy drug for prostate cancer, researchers said on…

New findings about how prostate cancer cells are able to resist hormone treatment and defy death may lead to more effective drug treatments, according to researchers from Wake Forest…

According to the World Health Organization there are about 250,000 new cases of prostate cancer every year but, when caught in time, the disease has a cure rate of over 90%.…

Pomegranate juice packs a punch on prostate cancer that prolongs post-surgery PSA doubling time, drives down cancer cell proliferation and causes prostate cancer cells to die,…

According to new research a daily glass of pomegranate juice may be effective in slowing down the progression of prostate cancer.

A study sponsored by a juice producer has found that…

It is well known that in addition to urethral catheter associated discomfort, there is an increased risk of ascending urethral infection, inflammation and stricture formation…

In patients with locally advanced prostate cancer and negative results on lymph node examination, immunochemical testing of the lymph node cells can spot the spread of cancer cells that are not…

Dr. Gregory Swanson and associates from the University of Texas, San Antonio Health Science Center reviews the data for various treatment options in patients with…

Men with prostate cancer make emotionally driven treatment decisions influenced by anecdote and misconception rather than consideration of clinical trial evidence, according to a new study.

Obese men have an increased risk of cancer recurrence after undergoing treatment with radiotherapy for localized prostate cancer, new research shows.

The findings “suggest a link to the biologic basis…

Prostate cancer (CaP) is a presumed result of both genetic and environmental events.

It is known that a positive family history and African-American ancestry will increase the risk of developing CaP…

Folate in the diet does not appear to lower the risk of developing prostate cancer, but does seem to influence disease severity somewhat, according to findings published in the…

Combining PSA with other risk factors for prostate cancer (CaP) may result in individualized risk prediction.

In the April 19, 2006 issue of the Journal of the National Cancer Institute, Dr.…

Surgery remains the most common treatment choice of men with prostate cancer, followed by hormone therapy and external beam radiation, according to the National Prostate Cancer Coalition’s (NPCC) annual Men’s…

A medication used to treat other types of cancer strangles drug-resistant, metastatic prostate cancer by cutting off its blood supply, researchers from The University of…

A medication used to treat other types of cancer strangles drug-resistant, metastatic prostate cancer by cutting off its blood supply, researchers from The University of Texas M. D. Anderson Cancer Center…

Recent studies suggest that testing blood for prostate specific antigen (PSA) alone does not produce an ideal predictor of prostate cancer, and emerging data suggest this is…